- This event has passed.
Deciphering and re-engineering the immune response to cancer
Event Agenda
9:30 AM – Vendor Show/Guest Check-In
10:30 AM – Vancouver-PBSS Welcome
10:45 AM – Deciphering and re-engineering the immune response to cancer
11:45 AM – Wrap-Up and Door Prizes
Speakers’ Bios
Brad Nelson, Ph.D.
Distinguished Scientist,
Scientific Director, Immunotherapy Program,
British Columbia Cancer Research Institute
Victoria BC, Canada
Dr. Nelson is a native of Vancouver, Canada. He received his B.Sc. from the University of British Columbia in 1987 and Ph.D. from the University of California at Berkeley in 1991. He completed postdoctoral training with Dr. Phil Greenberg and held faculty positions at the Fred Hutchinson Cancer Research Center and University of Washington in Seattle. In 2003, he became the founding Director of BC Cancer’s Deeley Research Centre in Victoria BC. He is a Professor of Medical Genetics at the University of British Columbia and a Professor of Biochemistry/Microbiology at the University of Victoria. He holds the Lynda and Murray Farmer Immunotherapy Research Chair at BC Cancer and is a Fellow of the Royal Society of Canada. Dr. Nelson’s lab uses genomic and molecular approaches to study the immune response to cancer. As Scientific Director of BC Cancer’s Immunotherapy Program, he is co-leading a phase I/II clinical trials program focused on engineered T cell therapies for lymphoid and gynecological cancers. Dr. Nelson is also a co-founder and CEO of Innovakine Therapeutics Inc, which is using protein and cell engineering approaches to improve the efficacy and safety of cell-based therapies. He has played the guitar since he was a kid and is currently working his way (very slowly) through music of the Baroque era.
Hosted by:
